**Author details**

S. Malhotra\* , S. Sharma, N. J. K. Bhatia, C. Hans and P. Kumar

\*Address all correspondence to: drshalinimalhotra@yahoo.com

Department of Microbiology, Dr. Ram Manohar Lohia Hospital and PGIMER, New Delhi, India

## **References**


[15] Akçakaya AA, Sargin F, Erbil HH, et al. A cluster of acute-onset postoperative en‐ dophthalmitis over a 1-month period: investigation of an outbreak caused by an un‐ common species. Br J Ophthalmol 2011;95:481–4.

**References**

36 Advances in Common Eye Infections

1998;43:193–224.

1992;36:454.

[1] Peyman G, Lee P, Seal DV. Endophthalmitis: Diagnosis and Management. Taylor &

[2] Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol

[3] Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical presentation, manage‐

[4] Moshfeghi A, Rosenfeld PJ, Flynn HW Jr, et al. Endophthalmitis after intravitreal an‐ ti-vascular endothelial growth factor antagonists: a six-year experience at a universi‐

[5] Marak Jr GE. Phacoanaphylactic endophthalmitis. Erratum in: Surv Ophthalmol

[6] Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic an‐

[7] Holland SP, Morck DW, Lee TL. Update on toxic anterior segment syndrome. Curr

[8] Carolee M, Cutler P, Jacob B, Sue C, Chris D, Henry EE, Nick M. Toxic anterior seg‐ ment syndrome: Common causes J Cataract Refractive Surg July 2010;36(7):1073–80.

[9] Stepien KE, Eaton AM, Jaffe GJ, Davis JL, Raja J, Feuer W. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in Spring 2006. Ret‐

[10] Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmi‐ tis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev

[11] Scott IU, Flynn HW, Feuer W, Pflugfelder SC, Alfonso EC, Forster RC, Miller D. En‐ dophthalmitis associated with microbial keratitis. Ophthalmology 1996;103:1864–70.

[12] Krause L, Bechrakis N, Heimann H, Kildal D, Foerster M. Incidence and outcome of

[13] Ramakrishnan R, Bharathi M, Shivkumar C, et al. Microbiological profile of cultureproven cases of exogenous and endogenous endophthalmitis: a ten-year retrospec‐

[14] Bahrani HM, Fazelat AA, Thomas M, et al. Endophthalmitis in the era of small gauge transconjunctival sutureless vitrectomy – meta analysis and review of the literature.

endophthalmitis over a 13-year period. Can J Ophthalmol 2009;44:88–94.

terior segment syndrome. J Cataract Refract Surg 2006;32:324–33.

Francis, London & New York: 2004, pp. 1–278.

ty referral center. Retina 2011;31:662–8.

Opin Ophthalmol 2007;18:4–8.

tive study. Eye (Lond) 2009;23:945–56.

Semi Ophthalmol 2010;25:275–82.

ina 2009;29:207–13.

2002;15:111–24.

ment, and perspective. Clin Ophthalmol 2010;4:121–35.


[43] Steptoe RJ, Holt PG, McMenamin PG. Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris. Immunology 1995;85:630–7.

[28] Vedantham V, Nirmalan PK, Ramasamy K, Prakash K, Namperumalsamy P. Clinicomicrobiological profile and visual outcomes of post-traumatic endophthalmitis at a

[29] Gupta A, Srinivasan R, Kaliaperumal S, Saha I. Post-traumatic fungal endophthalmi‐

[30] Callegan MC, Kane ST, Cochran DC, et al. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci 2005;46:3233–8.

[31] Romero CF, Rai MK, Lowder CY, and Adal KA. Endogenous endophthalmitis: case

[32] Binder MI, Chua J, Kaiser PK, et al. Endogenous endophthalmitis: an 18-year review of culture- positive cases at a tertiary care center. Medicine 2003;82:97–105.

[33] Ruhnke M, Rickerts V, Cornely OA, et al. Diagnosis and therapy of candida infec‐ tions: joint recommendations of the German Speaking Mycological Society and the

[34] Lamaris GA, Esmaeli B, Chamilos G, et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbial Infect Dis 2008;27:343–7.

[35] Safneck JR. Endophthalmitis: a review of recent trends. Saudi J Ophthalmol

[36] Khan A, Okhravi N, Lightman S. The eye in systemic sepsis. Clin Med 2002;2:444–8.

[37] Lundstrom M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and

[38] Behndig A, Montan P, Stenevi U, et al. One million cataract surgeries: Swedish Na‐

[39] Al-Mezaine HS, Kangave D, Al-Assiri A, Al-Rajhi AA. Acute-onset nosocomial en‐ dophthalmitis after cataract surgery: incidence, clinical features, causative organisms,

[40] Al-Mezaine HS, Al-Assiri A, Al-Rajhi AA. Incidence, clinical features, causative or‐ ganisms, and visual outcomes of delayed-onset pseudophakic endophthalmitis. Eur J

[41] Chaudhry IA, Shamsi FA, Elzaridi E, Al-Rashed W. Al-Amri AM, Al-Anezi F, Arat YO, Holck DEE. Outcome of treated orbital cellulitis from a tertiary eye care center in

[42] Cunha-Vaz JG. The blood-ocular barriers: past, present, and future. Doc Ophthalmol

tional Cataract Register 1992–2009, J Cat Refract Surg 2011;37:1539–45.

and visual outcomes. Cataract Refract Surg 2009;35:643–9.

the Middle East. Ophthalmology 2007;114:345–54.

Paul-Ehrlich-Society for Chemotherapy. Mycoses 2011;54:279–310.

tertiary eye care centre in South India. Indian J Ophthalmol 2006;54:5–10.

tis—a prospective study. Eye (Lond) 2008;22:13–7.

report and brief review. Am Fam Phys 1999;60:510–14.

location. Ophthalmology 2007;114:866–70.

Ophthalmol 2009;19:804–11.

1997;93:149–57.

2012;26:181–9.

38 Advances in Common Eye Infections

